Cargando…
Continuous Learning in Model‐Informed Precision Dosing: A Case Study in Pediatric Dosing of Vancomycin
Model‐informed precision dosing (MIPD) leverages pharmacokinetic (PK) models to tailor dosing to an individual patient’s needs, improving attainment of therapeutic drug exposure targets and thus potentially improving drug efficacy or reducing adverse events. However, selection of an appropriate mode...
Autores principales: | Hughes, Jasmine H., Tong, Dominic M. H., Lucas, Sarah Scarpace, Faldasz, Jonathan D., Goswami, Srijib, Keizer, Ron J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839485/ https://www.ncbi.nlm.nih.gov/pubmed/33068298 http://dx.doi.org/10.1002/cpt.2088 |
Ejemplares similares
-
Model-Informed Precision Dosing of Vancomycin in Hospitalized Children: Implementation and Adoption at an Academic Children’s Hospital
por: Frymoyer, Adam, et al.
Publicado: (2020) -
Model‐Informed Precision Dosing at the Bedside: Scientific Challenges and Opportunities
por: Keizer, Ron J., et al.
Publicado: (2018) -
Evaluation of Neonatal and Paediatric Vancomycin Pharmacokinetic Models and the Impact of Maturation and Serum Creatinine Covariates in a Large Multicentre Data Set
por: Hughes, Jasmine H., et al.
Publicado: (2022) -
Assessment of a Model-Informed Precision Dosing Platform Use in Routine Clinical Care for Personalized Busulfan Therapy in the Pediatric Hematopoietic Cell Transplantation (HCT) Population
por: Shukla, Praveen, et al.
Publicado: (2020) -
2540. Can aminoglycoside dosing be improved through use of pharmacokinetic models from other aminoglycosides?
por: Faldasz, Jonathan, et al.
Publicado: (2023)